China Foods Holdings Ltd. (CFOO): Cost of Revenue

Annual figures by period end, from SEC filings.

$297.9K
Year ended 2025-12-31
$171.3K
Trailing 12 months to 2026-06-30
+7.0%
3-year compound annual growth
-13.0%
5-year compound annual growth
$2.66M2019-12-31: $2.66M2020-12-31: $596.5K2021-12-31: $121.7K2022-12-31: $243.0K2023-12-31: $94.3K2024-12-31: $179.5K2025-12-31: $297.9K$297.9K
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$297.9K+66.0%2026-04-16, From 2025-01-01
2024-12-31$179.5K+90.3%2026-04-16, From 2024-01-01
2023-12-31$94.3K-61.2%2025-04-14, From 2023-01-01
2022-12-31$243.0K+99.7%2024-04-16, From 2022-01-01
2021-12-31$121.7K-79.6%2023-03-31, From 2021-01-01
2020-12-31$596.5K-77.6%2023-02-07, From 2020-01-01
2019-12-31$2.66Mn/a2021-04-13, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
China Foods Holdings Ltd. (CFOO)2025-12-31$297.9K+66.0%
Nutra Pharma Corp (NPHC)2025-12-31$183.7K+116.5%
Adia Med, Inc. (ADIA)2025-12-31$508.8Kn/m
TFA Therapeutics, Inc. (RAJAF)2025-12-31$484.6K+39.7%
Target Group Inc. (CBDY)2025-12-31$1.81M-36.7%
Healthy Extracts Inc. (HYEX)2025-12-31$2.09M+73.8%
Functional Brands Inc. (MEHA)2025-12-31$3.13M+5.7%
Bon Natural Life Ltd (BON)2025-09-30$14.79M-11.6%
Charlie's Holdings, Inc. (CHUC)2025-12-31$15.26M+212.2%

Compare CFOO, NPHC, ADIA, RAJAF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗